DarioHealth Corp. SEC filings DRIO

DarioHealth Corp. has 903 filings in SEC EDGAR's recent list, going back to Nov 1, 2011. Its latest annual report, Form 10-K, was filed on Mar 19, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 4, 2026 (officer or director change). The company's fiscal year ends on December 31.

DarioHealth Corp. SEC filings
Form Description Filed Period
4 Insider transaction Sep 28, 2026 Sep 24, 2026
4 Insider transaction Sep 28, 2026 Sep 18, 2025
4 Insider transaction Sep 28, 2026 Sep 24, 2026
4 Insider transaction Sep 28, 2026 Aug 12, 2024
4 Insider transaction Sep 28, 2026 Sep 24, 2026
4 Insider transaction Sep 28, 2026 Sep 24, 2026
4 Insider transaction Sep 28, 2026 Sep 24, 2026
4 Insider transaction Sep 28, 2026 Aug 12, 2024
3 Initial insider ownership Sep 28, 2026 Sep 24, 2026
8-K Current report
Officer or director change
Sep 4, 2026 Sep 2, 2026
8-K Current report
Officer or director change
Aug 21, 2026 Aug 20, 2026
10-Q Quarterly report Aug 11, 2026 Jun 30, 2026
4 Insider transaction Jul 28, 2026 Aug 12, 2024
8-K Current report
Material agreement, Other events
Jul 22, 2026 Jul 22, 2026
424B5 Prospectus supplement Jul 22, 2026 —
8-K Current report
Officer or director change
Jul 10, 2026 Jul 10, 2026
10-Q Quarterly report May 13, 2026 Mar 31, 2026
SD Specialized disclosure (conflict minerals) May 7, 2026 —
3 Initial insider ownership Apr 13, 2026 Apr 10, 2026
8-K Current report
Officer or director change, Other events
Apr 13, 2026 Apr 10, 2026
424B5 Prospectus supplement Mar 30, 2026 —
8-K Current report
Material agreement
Mar 30, 2026 Mar 30, 2026
EFFECT Filing Mar 27, 2026 —
CORRESP Letter to the SEC Mar 25, 2026 —
UPLOAD Letter from the SEC Mar 25, 2026 —
S-8 Employee stock plan registration Mar 19, 2026 —
S-3 Shelf registration Mar 19, 2026 —
10-K Annual report Mar 19, 2026 Dec 31, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 13, 2026 —
8-K Current report
Bylaw or fiscal year change
Feb 2, 2026 Feb 2, 2026
8-K Current report
Shareholder vote results
Jan 29, 2026 Jan 29, 2026
EFFECT Filing Jan 8, 2026 —
CORRESP Letter to the SEC Jan 6, 2026 —
S-3/A Form s-3/a Dec 29, 2025 —
ARS Annual report to shareholders Dec 22, 2025 Dec 31, 2024
DEF 14A Proxy statement Dec 22, 2025 Jan 29, 2026
SCHEDULE 13G Ownership over 5% (passive) Dec 16, 2025 —
PRE 14A Preliminary proxy statement Dec 11, 2025 Dec 11, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
10-Q Quarterly report Nov 13, 2025 Sep 30, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 12, 2025 —
8-K Current report
Material agreement, New debt, Unregistered share sale
Nov 10, 2025 Nov 5, 2025
S-3 Shelf registration Oct 20, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 9, 2025 —
D Filing Oct 7, 2025 —
8-K Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change, Other events
Sep 25, 2025 Sep 25, 2025
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change
Sep 19, 2025 Sep 18, 2025
4 Insider transaction Sep 15, 2025 Sep 11, 2025
4 Insider transaction Sep 15, 2025 Sep 11, 2025
4 Insider transaction Sep 15, 2025 Sep 11, 2025
4 Insider transaction Sep 15, 2025 Sep 11, 2025
4 Insider transaction Sep 15, 2025 Sep 11, 2025
4 Insider transaction Sep 15, 2025 Sep 11, 2025
4 Insider transaction Sep 15, 2025 Sep 11, 2025
4 Insider transaction Sep 15, 2025 Sep 11, 2025
4 Insider transaction Sep 15, 2025 Sep 11, 2025
8-K Current report
Other events
Sep 12, 2025 Sep 12, 2025
4 Insider transaction Aug 27, 2025 Aug 27, 2025
8-K Current report
Bylaw or fiscal year change, Other events
Aug 25, 2025 Aug 25, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
10-Q Quarterly report Aug 12, 2025 Jun 30, 2025
EFFECT Filing Aug 7, 2025 —
CORRESP Letter to the SEC Aug 5, 2025 —
UPLOAD Letter from the SEC Aug 5, 2025 —
S-3 Shelf registration Jul 31, 2025 —
8-K Current report
Shareholder vote results
Jul 23, 2025 Jul 23, 2025
SCHEDULE 13G Ownership over 5% (passive) Jul 22, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 18, 2025 —
8-K Current report
Officer or director change
Jul 10, 2025 Jul 10, 2025
EFFECT Filing Jun 5, 2025 —
CORRESP Letter to the SEC Jun 4, 2025 —
UPLOAD Letter from the SEC Jun 2, 2025 —
SD Specialized disclosure (conflict minerals) Jun 2, 2025 —
DEF 14A Proxy statement May 30, 2025 Jul 23, 2025
8-K Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change
May 29, 2025 May 23, 2025
S-3 Shelf registration May 28, 2025 —
8-K Current report
Bylaw or fiscal year change
May 21, 2025 May 20, 2025
PRE 14A Preliminary proxy statement May 20, 2025 May 20, 2025
4 Insider transaction May 15, 2025 May 15, 2025
3 Initial insider ownership May 15, 2025 May 15, 2025
10-Q Quarterly report May 14, 2025 Mar 31, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) May 13, 2025 —
8-K Current report
Material agreement, New debt, Unregistered share sale
May 6, 2025 Apr 30, 2025
8-K Current report
Shareholder vote results
Apr 28, 2025 Apr 28, 2025
8-K Current report
Officer or director change
Apr 21, 2025 Apr 18, 2025
8-K Current report
Listing notice
Mar 19, 2025 Mar 18, 2025
8-K Current report
Officer or director change
Mar 14, 2025 Mar 12, 2025
DEF 14A Proxy statement Mar 10, 2025 Apr 28, 2025
10-K Annual report Mar 10, 2025 Dec 31, 2024
3 Initial insider ownership Mar 7, 2025 Feb 25, 2025
SCHEDULE 13G Ownership over 5% (passive) Mar 6, 2025 —
PRE 14A Preliminary proxy statement Feb 28, 2025 Feb 28, 2025
8-K Current report
Officer or director change, Other events
Feb 27, 2025 Feb 24, 2025
4 Insider transaction Feb 25, 2025 Feb 24, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 12, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 12, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 12, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 4, 2025 —
8-K Current report
Other events
Jan 22, 2025 Jan 21, 2025
D Filing Jan 17, 2025 —
D Filing Jan 17, 2025 —
S-8 Employee stock plan registration Jan 17, 2025 —
8-K Current report
Material agreement, Unregistered share sale
Jan 10, 2025 Jan 7, 2025
4 Insider transaction Jan 10, 2025 Jan 7, 2025
SCHEDULE 13G Ownership over 5% (passive) Jan 8, 2025 —
8-K Current report
Material agreement, New debt, Unregistered share sale, Other events
Dec 18, 2024 Dec 16, 2024
8-K Current report
Shareholder vote results
Dec 18, 2024 Dec 18, 2024
SC 13G Ownership over 5% (passive) Dec 13, 2024 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
4 Insider transaction Nov 14, 2024 Nov 12, 2024
10-Q Quarterly report Nov 7, 2024 Sep 30, 2024
SC 13G Ownership over 5% (passive) Oct 29, 2024 —
DEF 14A Proxy statement Oct 24, 2024 Dec 18, 2024
8-K Current report
Listing notice
Sep 20, 2024 Sep 16, 2024
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change
Sep 13, 2024 Sep 11, 2024
4 Insider transaction Sep 12, 2024 Sep 10, 2024
4 Insider transaction Sep 10, 2024 Sep 5, 2024
4 Insider transaction Aug 28, 2024 Aug 27, 2024
4 Insider transaction Aug 23, 2024 Aug 21, 2024
4 Insider transaction Aug 23, 2024 Aug 20, 2024
4 Insider transaction Aug 20, 2024 Aug 19, 2024
4 Insider transaction Aug 20, 2024 Aug 16, 2024
10-Q Quarterly report Aug 8, 2024 Jun 30, 2024
S-8 Employee stock plan registration Jul 5, 2024 —
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change
Jun 28, 2024 Jun 25, 2024
8-K Current report
Officer or director change, Shareholder vote results
Jun 25, 2024 Jun 25, 2024
4 Insider transaction Jun 7, 2024 Jun 5, 2024
3 Initial insider ownership Jun 7, 2024 Jun 5, 2024
8-K Current report
Officer or director change
Jun 5, 2024 Jun 5, 2024
10-Q Quarterly report May 15, 2024 Mar 31, 2024
EFFECT Filing May 8, 2024 —
CORRESP Letter to the SEC May 6, 2024 —
S-3/A Form s-3/a May 3, 2024 —
DEF 14A Proxy statement May 1, 2024 Jun 25, 2024
UPLOAD Letter from the SEC Apr 30, 2024 —
S-3 Shelf registration Apr 22, 2024 —
8-K Current report
Acquisition or sale of assets
Apr 22, 2024 Feb 15, 2024
PRE 14A Preliminary proxy statement Apr 19, 2024 Jun 25, 2024
8-K Current report
Bylaw or fiscal year change
Apr 19, 2024 Apr 16, 2024
424B3 Prospectus Apr 19, 2024 —
8-K Current report
Officer or director change
Apr 5, 2024 Apr 4, 2024
10-K Annual report Mar 28, 2024 Dec 31, 2023
4 Insider transaction Mar 8, 2024 Mar 6, 2024
4 Insider transaction Mar 8, 2024 Mar 6, 2024
4 Insider transaction Mar 8, 2024 Mar 6, 2024
4 Insider transaction Mar 8, 2024 Mar 6, 2024
4 Insider transaction Mar 8, 2024 Mar 6, 2024
4 Insider transaction Mar 8, 2024 Mar 6, 2024
4 Insider transaction Mar 8, 2024 Mar 6, 2024
4 Insider transaction Mar 8, 2024 Mar 6, 2024
4 Insider transaction Mar 8, 2024 Mar 6, 2024
8-K Current report
Other events
Mar 1, 2024 Mar 1, 2024
4 Insider transaction Mar 1, 2024 Feb 15, 2024
D Filing Feb 29, 2024 —
8-K Current report
Regulation FD disclosure
Feb 22, 2024 Feb 22, 2024
4 Insider transaction Feb 21, 2024 Feb 15, 2024
3 Initial insider ownership Feb 21, 2024 Feb 15, 2024
S-8 Employee stock plan registration Feb 21, 2024 —
8-K Current report
Material agreement, New debt, Unregistered share sale, Officer or director change, Regulation FD disclosure, Other events
Feb 21, 2024 Feb 15, 2024
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 6, 2024 —
S-8 Employee stock plan registration Jan 19, 2024 —
8-K Current report
Shareholder vote results
Dec 11, 2023 Dec 11, 2023
10-Q Quarterly report Nov 2, 2023 Sep 30, 2023
DEF 14A Proxy statement Oct 26, 2023 Dec 11, 2023
8-K Current report
Regulation FD disclosure
Oct 17, 2023 Oct 17, 2023
PRE 14A Preliminary proxy statement Oct 16, 2023 Dec 11, 2023
SC 13G/A Amended ownership over 5% (passive) Sep 8, 2023 —
10-Q Quarterly report Aug 10, 2023 Jun 30, 2023
8-K Current report
Results of operations, Other events
Jul 24, 2023 Jul 24, 2023
EFFECT Filing Jul 13, 2023 —
CORRESP Letter to the SEC Jul 12, 2023 —
S-3/A Form s-3/a Jul 10, 2023 —
UPLOAD Letter from the SEC Jul 7, 2023 —
S-3 Shelf registration Jun 29, 2023 —
8-K Current report
Material agreement, Change to shareholder rights, Bylaw or fiscal year change
Jun 20, 2023 Jun 14, 2023
SD Specialized disclosure (conflict minerals) Jun 7, 2023 —
D Filing May 16, 2023 —
10-Q Quarterly report May 11, 2023 Mar 31, 2023
8-K/A Amended current report
Material agreement, Agreement ended, New debt, Unregistered share sale, Bylaw or fiscal year change, Other events
May 9, 2023 May 1, 2023
4 Insider transaction May 8, 2023 May 4, 2023
4 Insider transaction May 8, 2023 May 4, 2023
4 Insider transaction May 8, 2023 May 4, 2023
4 Insider transaction May 8, 2023 May 4, 2023
8-K Current report
Material agreement, Agreement ended, New debt, Unregistered share sale, Bylaw or fiscal year change, Other events
May 5, 2023 May 1, 2023
8-K Current report
Regulation FD disclosure
Mar 10, 2023 Mar 10, 2023
10-K Annual report Mar 9, 2023 Dec 31, 2022
3 Initial insider ownership Mar 3, 2023 Feb 22, 2023
8-K Current report
Officer or director change, Other events
Feb 24, 2023 Feb 22, 2023
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2023 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2023 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2023 —
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2023 —
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2023 —
8-K Current report
Results of operations, Regulation FD disclosure
Feb 6, 2023 Jan 31, 2023
8-K Current report
Officer or director change
Jan 27, 2023 Jan 23, 2023
4 Insider transaction Jan 18, 2023 Jan 13, 2023
8-K Current report
Other events
Jan 13, 2023 Jan 9, 2023

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
DRIO (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
New York, NY
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1533998
Former names
LabStyle Innovations Corp. (until Jul 27, 2016)

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.